Khalili, Hamed
Chan, Simon S. M.
Lochhead, Paul
Ananthakrishnan, Ashwin N.
Hart, Andrew R.
Chan, Andrew T. http://orcid.org/0000-0001-7284-6767
Article History
First Online: 22 May 2018
Competing interests
: H.K. has received consulting fees from AbbVie and Samsung Bioepis. H.K. also receives funding from Takeda. S.S.M.C. has received consulting fees from AbbVie and Ferring Pharmaceuticals. P.L. is supported by a career development grant by the Crohn’s and Colitis Foundation (CCF). A.N.A. is a member of the scientific advisory board for Exact Sciences, AbbVie and Cubist Pharmaceuticals. A.T.C. has served as a consultant for Bayer Healthcare, Pfizer and Takeda. A.R.H. declares no competing interests.